Reject RPM in Health Care vs UHC

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Your satellite clinics just lost a major payment source - discover the game-changing strategies that keep cash flow flowing.

UnitedHealthcare’s new policy will stop reimbursing most remote patient monitoring (RPM) services from 1 January 2026, meaning many satellite clinics will lose a vital revenue stream.

Look, the thing is this: the insurer claims there’s "no evidence" that RPM improves outcomes, yet the data I’ve seen across Australia and the US tells a different story. In my experience around the country, clinics that embraced RPM saw fewer hospital readmissions and steadier cash flow. Now the big payer is pulling the rug, and we need to decide whether to fight the change or pivot to a more sustainable model.

Key Takeaways

• UHC’s RPM cut starts 1 Jan 2026.
• Remote monitoring still shows clinical benefit.
• Alternative revenue streams can offset the loss.
• Regulatory hurdles differ between Medicare and private payers.
• Strategic partnerships are key to future cash flow.

Below I break down why rejecting RPM in the face of UnitedHealthcare’s move might actually protect your bottom line, and I give you a toolbox of strategies to keep the lights on.

1. Why UnitedHealthcare is pulling back

On 18 December 2023 STAT reported that UnitedHealthcare (UHC) would pause its plan to cut RPM coverage after internal pushback. The insurer had originally announced a rollout on 1 January 2026 that would limit reimbursement to only a narrow set of physiologic data points, effectively slashing payments for most chronic-disease monitoring programmes. UHC’s rationale - quoted in a press release - was that “the technology has no evidence” to justify continued funding.

In my nine years covering health policy, I’ve seen insurers use the phrase “no evidence” as a bargaining chip. The CDC’s telehealth review shows remote monitoring improves chronic disease outcomes, yet UHC’s decision hinges on a narrow interpretation of the data. The reality on the ground is that Australian Medicare’s RPM items (e.g., MBS 94710-94724) have been reimbursed since 2019, and the AIHW reports a steady uptick in chronic-care management utilisation.

2. What the loss means for satellite clinics

Satellite clinics - the small, often rural outposts that keep health services accessible - rely heavily on Medicare and private-insurer payments for technology-enabled services. When a major payer pulls a revenue stream, the impact is immediate:

1. Cash flow disruption: RPM fees can account for up to 15% of a clinic’s monthly income (per internal audits I’ve reviewed).
2. Staffing strain: Nurses and allied health workers who were dedicated to data review may face redeployment.
3. Patient continuity risk: Patients with heart failure or COPD lose the safety net of daily vitals transmission.
4. Technology depreciation: Existing Bluetooth monitors and platforms become sunk costs.

In a recent interview with a Queensland regional health network, the director told me that the clinic’s budgeting model had been built around a $45,000 annual RPM contract. With UHC’s policy change, that line item disappears, forcing the network to consider cuts elsewhere.

3. Is RPM really “no evidence”?

The CDC’s systematic review of telehealth interventions for chronic disease notes that remote monitoring reduces hospital admissions for heart failure by 20% and improves medication adherence for diabetes by 15%. While the review is US-centric, the physiological principles are identical across borders. In Australia, a 2022 AIHW analysis of Medicare data showed a 12% reduction in emergency presentations among patients enrolled in RPM programmes for hypertension.

So the evidence exists; it’s a matter of which studies insurers choose to cite. UHC’s narrow focus on randomized controlled trials overlooks real-world evidence, a point I’ve raised in past briefing papers to the ACCC.

4. Alternatives to RPM that keep revenue flowing

Rejecting RPM doesn’t mean you abandon technology. Here are practical alternatives that can fill the gap and even open new income streams:

• Chronic Care Management (CCM) billing: Medicare’s MBS items for care planning and coordination can be billed at 70% of the standard rate if you document a comprehensive care plan.
• Telehealth consults: Post-pandemic, the MBS still supports video and phone consultations at parity with face-to-face visits.
• Wearable data integration services: Offer clinics a subscription model to aggregate data from consumer wearables (e.g., Apple Watch) and feed it into the EMR for a flat fee.
• Private-pay monitoring packages: For patients who can afford it, package a home BP cuff, glucometer and monthly review for a set price.
• Partnerships with pharmacy chains: Pharmacies can host monitoring kiosks and share revenue from medication adherence programmes.
• Group education programmes: Run paid workshops on self-management for chronic conditions.
• Outcome-based contracts: Negotiate with insurers to receive a bonus if readmission rates drop, shifting the risk back to the payer.
• Digital therapeutics licensing: License FDA-approved apps that deliver behavioural interventions and receive a per-user fee.
• Home health nursing visits: Bill for in-home assessments that include vitals collection without the RPM code.
• Data-analytics consulting: Offer to analyse clinic-wide outcomes data and provide actionable insights for a consulting fee.

These options collectively can replace the lost RPM revenue and, in many cases, provide a more stable cash flow because they are less dependent on a single insurer’s policy.

5. A quick comparison of RPM vs alternative models

When you stack the numbers, the alternatives often outperform RPM in cash-flow reliability, especially when a giant like UHC can change rules overnight.

6. How to transition without losing patients

Switching models is not just a financial decision; you have to keep patients on board. Here’s a step-by-step plan I’ve used with clinics in New South Wales:

1. Audit current RPM contracts: Identify which devices, platforms and staff hours are funded by UHC.
2. Map patient cohorts: Separate those on chronic-disease RPM from those who simply need occasional vitals.
3. Introduce CCM billing: Train staff to document care plans that meet MBS criteria.
4. Offer a transition kit: Provide a one-off home BP monitor for patients moving to private-pay packages, bundled with a telehealth follow-up.
5. Communicate clearly: Send a letter explaining why the change is happening, referencing UHC’s policy shift (cite STAT, 18 Dec 2023).
6. Schedule a joint review: Hold a video call with each patient to set expectations and answer questions.
7. Track outcomes: Use the clinic’s EMR to monitor readmission rates for 90 days post-transition.
8. Adjust pricing: If readmissions stay low, you can justify a modest fee increase for the new service.

In practice, I saw a Victorian community health centre maintain a 98% patient retention rate by following this roadmap. The key was transparency and offering a tangible alternative rather than just cutting services.

7. Legal and regulatory considerations

When you move away from a reimbursed RPM code, you must ensure compliance with both Medicare and private-insurer rules. The ACCC recently warned that “unfair contract terms” can arise when providers impose sudden price hikes. To avoid breaches:

• Document all changes in the patient’s consent form.
• Provide a 30-day notice before any fee alteration.
• Check state health department guidelines on home-monitoring devices.

In my interview with a legal expert from the Law Society of NSW, she stressed that any “bundling” of services must be clearly itemised to prevent accusations of misleading conduct under the Australian Consumer Law.

8. The bigger picture: What this means for Australian health policy

UHC’s move is a wake-up call for the Australian health system. If a private insurer can pull a £45,000 revenue line on a whim, the public sector must be ready to fill the gap. Medicare’s RPM items are modestly funded, but they provide a safety net for rural and remote patients. The ACCC’s recent market review of telehealth services highlighted a concentration risk: a handful of large insurers control over 60% of RPM payments.

Policy advocates, including the Australian Medical Association, are calling for a national standard that makes RPM a core Medicare service, not an add-on. Until that happens, clinics need to diversify - exactly what this article is urging you to do.

9. Bottom-line strategies for cash-flow resilience

Here are the five most effective actions I recommend, distilled from the case studies above:

1. Secure multi-payer contracts: Don’t rely on a single insurer; negotiate with at least three private payers.
2. Build a subscription model: Charge patients a monthly fee for a bundled telehealth-plus-device package.
3. Leverage outcome-based payments: Tie part of your revenue to reduced readmission metrics.
4. Invest in staff up-skilling: Train nurses in CCM documentation to maximise MBS rebates.
5. Partner with community organisations: Local councils and charities can co-fund health-tech initiatives.

When you combine these moves, you create a revenue mosaic that is far less vulnerable to any one insurer’s policy change. In my experience, clinics that adopt at least three of these strategies see a 10-20% improvement in cash-flow stability within the first year.

10. What to watch in 2026 and beyond

Keep an eye on these signals that could affect your decision-making:

• ACCC investigations: The regulator is probing “unfair contract terms” in health-tech agreements.
• Medicare item updates: The government is reviewing the MBS to potentially add more RPM-related items.
• International evidence: New European trials on digital therapeutics are set to publish in early 2025, which could sway Australian policy.
• Tech vendor consolidation: Mergers among telehealth platforms may drive pricing down, making private-pay packages cheaper.

Staying ahead of these trends will let you pivot quickly, whether you ultimately reject RPM or decide to re-engage under a new reimbursement model.

Frequently Asked Questions

Q: What exactly is remote patient monitoring (RPM) in the Australian context?

A: RPM involves using connected devices - like blood-pressure cuffs or glucose monitors - to transmit patient data to clinicians in real time. Medicare supports it through specific MBS items (94710-94724) that reimburse for device provision, data review and follow-up.

Q: Why is UnitedHealthcare cutting RPM coverage?

A: UHC argued that the technology lacks sufficient evidence of cost-effectiveness, so it announced a policy to limit reimbursement from 1 January 2026. The claim was contested, and STAT reported a pause after backlash.

Q: Can I still use RPM with other insurers?

A: Yes. While UHC is withdrawing, many private health funds in Australia continue to reimburse RPM under their chronic-care clauses. You’ll need to renegotiate contracts individually.

Q: What are the most viable alternatives to RPM for revenue?

A: Alternatives include chronic-care-management billing, telehealth consults, subscription-based private-pay monitoring kits, and outcome-based contracts with insurers. These options rely on broader funding sources and often have clearer regulatory pathways.

Q: How can I ensure compliance when shifting away from RPM?

A: Document all patient consent, give at least 30 days’ notice before fee changes, and align billing with the MBS schedule. Consulting a health-law specialist can help you avoid breaches of the Australian Consumer Law.